Aptorum Group Limited Class A - ADR Peer Comparison

$8.41

$0.09 (1.08%)

As on 27-Jul-2026 09:30EDT

Market cap

$1 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

0.3

Div. Yield

0 %

Edit

	Aptorum Group Limited Class A - ADR	Theravance Biopharma (TBPH)
Market cap ($ Mln)	1	885
Revenue ($ Mln)	1	104
Net Profit ($ Mln)	-5.68	53.81
Net Margin (%)	-591.67	51.58
RoE (%)	-49.04	18.35
Price to Earnings	--	16.39
Price-To-Book	0.28	3.05

Cashflow
Ratios

Cashflow ($ Mln)

	Aptorum Group Limited Class A - ADR	Theravance Biopharma (TBPH)
Cash From Operating Activities	-1.84	238.54
Cash Flow from Investing Activities	--	-105.28
Cash from Financing Activities	4.41	-3.25
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	Aptorum Group Limited Class A - ADR	Theravance Biopharma (TBPH)
ROCE (%)	-5.34	35.44
ROE (%)	-49.04	18.35
ROA (%)	-59.31	7.87
EBIT Margin (%)	0.00	61.61
Net Margin (%)	-591.67	51.58
Cash Profit Margin (%)	--	0.00

Growth Ratios

	Aptorum Group Limited Class A - ADR	Theravance Biopharma (TBPH)
Revenue Growth (%)	--	35.11
EBIT Growth (%)	--	50.13
Net Profit Growth (%)	68.06	312.92
EPS Growth (%)	0.98	331.49
Book Value Growth (%)	--	26.50

Valuation Ratios

	Aptorum Group Limited Class A - ADR	Theravance Biopharma (TBPH)
Price / Earnings	-5.72	9.37
Price / Book Value	0.34	3.05
Dividend Yield (%)	--	0.00
EV/EBITDA	-4.28	9.43
Market Cap ($ Cr)	--	--

Solvency Ratios

	Aptorum Group Limited Class A - ADR	Theravance Biopharma (TBPH)
Debt to Equity	0.00	0.00
Short term debt to equity ratio	74.65	0.04
Current Ratio	0.45	13.54
Quick Ratio	0.45	13.54
Interest Coverage	-35.64	51.97

Operating Efficiency Ratios

	Aptorum Group Limited Class A - ADR	Theravance Biopharma (TBPH)
Debtors to sales (%)	0.00	19.54
Asset Turnover	0.10	0.15
Receivable days	--	278.67
Inventory Days	--	-4,537.51
Payable days	--	159.28
Cash Conversion Cycle	--	-4,418.12

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly